Six months after Merck & Co.'s manufacturing operations were crippled by a global cyberattack, the company says it has mostly recovered from the computer hack that took out its API production and ...
Facing vaccine pressures in multiple markets, Merck & Co. is pruning the ranks at one of its key U.S. production facilities. In a Worker Adjustment and Retraining Notification (WARN) Act alert filed ...
Merck plans to invest up to $1 billion in stages over the next three years to expand its manufacturing operation in Rockingham County. The company will add 120,000 square feet to its existing 1.1 ...
Merck on Monday announced the groundbreaking of its new Virginia pharmaceutical manufacturing facility, a cornerstone of the company’s $70 billion U.S. investment strategy. The 400,000-square-foot ...
Hosted on MSN
Merck highlights $9B manufacturing investment through 2028 as Q1 2025 revenues reach $15.5B
CEO Rob Davis highlighted the progress in commercialized medicines and vaccines, emphasizing the strength of newer product launches such as WINREVAIR and CAPVAXIVE. Revenue for Q1 2025 reached $15.5 ...
KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, reaffirmed its commitment to enable broad equitable access to the company’s HPV vaccines. To ...
A new manufacturing plant in De Soto will be a Center of Excellence for the global company, along with expanded R&D capabilities at the site. Merck Animal Health is expanding its manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results